Karen Ferrante

Dr. Karen J.
Ferrante, MD, is an Independent Director at Cogent Biosciences, Inc. She is on the Board of Directors at Cogent Biosciences, Inc. and New England Women In Science Executives Club.
Dr. Ferrante was previously employed as an Independent Non-Executive Director by HUTCHMED (China) Ltd., an Independent Director by MacroGenics, Inc., an Independent Director by Baxalta, Inc., a Chief Medical Officer, Head-Research & Technology by Tokai Pharmaceuticals, Inc., an Independent Director by Progenics Pharmaceuticals, Inc., a Head-Oncology Therapeutic Area by Takeda Oncology Co., a Head-Oncology Therapeutic Area by Takeda Pharmaceutical Co., Ltd., a Vice President-Oncology Development by Pfizer Inc., an Associate Director by Bristol Myers Squibb Co., and a Vice President-Oncology Department by Pfizer (St. Louis).
She received her undergraduate degree from Providence College and a doctorate degree from Georgetown University.